Latest News

Latest News

SABR May Be New Standard Care for Primary RCC Not Suitable for Surgery 

By

Bryant Furlow

Publish Date October 4, 2023

SABR may be a new standard of care for primary RCC that is not suitable for surgery, according to a presentation at ASTRO 2023.

Regimen May Eliminate Need for Transplant in Low-Risk Hodgkin Lymphoma

By

Bryant Furlow

Publish Date October 4, 2023

Nivolumab plus brentuximab vedotin, followed by ISRT, appears safe and effective for low-risk, relapsed classical Hodgkin lymphoma.

PPI Use During Adjuvant Chemo Tied to Worse PFS, OS in Endometrial Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date October 4, 2023

Proton pump inhibitor (PPI) use may negatively impact chemotherapy outcomes in patients with endometrial cancer, a study suggests.

Takeda to Withdraw Lung Cancer Drug Exkivity From US Market

By

Brian Park, PharmD

Publish Date October 4, 2023

Takeda is initiating a voluntary withdrawal of Exkivity (mobocertinib) from the US market, following negative results from a phase 3 trial.

FDA Clears Test That Detects Hereditary Gene Variants Linked to Certain Cancers

By

Brian Park, PharmD

Publish Date October 4, 2023

The FDA has cleared Invitae Common Hereditary Cancers Panel, a diagnostic test that detects hundreds of hereditary cancer gene variants.

Pharma Companies Agree to Medicare Drug Price Negotiations

Publish Date October 4, 2023

Pharmaceutical companies have agreed to negotiate prices for 10 drugs.

Biomarker-Guided First-Line Treatment Improves OS in Advanced NSCLC

By

Leah Lawrence

Publish Date October 3, 2023

First-line treatment guided by biomarker testing results improves survival in patients with advanced non-small cell lung cancer, a study suggests.

Best Outcomes With First-Line Treatment for Unresectable ESCC

By

Leah Lawrence

Publish Date October 3, 2023

Researchers have identified first-line treatment regimens that appear to be associated with the best outcomes in advanced, unresectable ESCC.

Use of Palliative Care in Metastatic Breast Cancer Varies by Race/Ethnicity

By

Julie Ehlers

Publish Date October 3, 2023

New research suggests that, in the United States, the use of palliative care for metastatic breast cancer varies by race.

Many Oncology Practices Do Not Screen for Caregiver Well-Being

Publish Date October 3, 2023

Caregivers of adult cancer patients are not typically screened for distress, a new study suggests.